<DOC>
	<DOCNO>NCT01254591</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , positron emission tomography/computed tomography ( PET/CT ) scan surgery , may help measure extent disease . PURPOSE : This clinical trial study PET/CT scan surgery patient non-small cell lung cancer , colorectal cancer , breast cancer , esophageal cancer , head neck cancer .</brief_summary>
	<brief_title>Positron Emission Tomography/Computed Tomography Scanning Before Surgery Patients With Non-Small Cell Lung Cancer , Colorectal Cancer , Breast Cancer , Esophageal Cancer , Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine ability preoperative fludeoxyglucose F 18 positron emission tomography/computed tomography ( PET/CT ) scan assess tumor angiogenesis patient potentially operable non-small cell lung cancer , colorectal cancer , breast cancer , esophageal cancer , head neck cancer . - To determine ability preoperative fludeoxyglucose F 18 PET/CT scan assess prognosis mean measure angiogenesis patient . OUTLINE : All patient undergo fludeoxyglucose F 18 positron emission tomography/computed tomography ( PET/CT ) scan staging , tumor perfusion measurement/angiogenesis , glucose metabolism . If stag confirms operable disease , patient proceeds surgery plan . Resected tumor tissue sample examine tumor angiogenesis various cancer type . Some patient undergo half-dose rubidium Rb-82 18F-fluoromisonidazole [ 18F ] -ML-10 PET scan fluorescence angiography . Patients colorectal cancer undergo CT scan perfusion tumor stag PET/CT . Patients breast cancer undergo infrared thermometry well MRI scan stag predict angiogenesis . After completion study therapy , patient follow 1 month every 6 month 5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Misonidazole</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonsmall cell lung cancer , colorectal cancer , breast cancer , esophageal cancer , head neck cancer Potentially operable disease Hormone receptor status specify PATIENT CHARACTERISTICS : Not specify Menopausal status specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>stage IA non-small cell lung cancer</keyword>
	<keyword>stage IB non-small cell lung cancer</keyword>
	<keyword>stage IIA non-small cell lung cancer</keyword>
	<keyword>stage IIB non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage IIA colon cancer</keyword>
	<keyword>stage IIB colon cancer</keyword>
	<keyword>stage IIC colon cancer</keyword>
	<keyword>stage IIIA colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage IIA rectal cancer</keyword>
	<keyword>stage IIB rectal cancer</keyword>
	<keyword>stage IIC rectal cancer</keyword>
	<keyword>stage IIIA rectal cancer</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage I hypopharyngeal cancer</keyword>
	<keyword>stage II hypopharyngeal cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage I laryngeal cancer</keyword>
	<keyword>stage II laryngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage I lip oral cavity cancer</keyword>
	<keyword>stage II lip oral cavity cancer</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage I nasopharyngeal cancer</keyword>
	<keyword>stage II nasopharyngeal cancer</keyword>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage I oropharyngeal cancer</keyword>
	<keyword>stage II oropharyngeal cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage I paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage II paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>tongue cancer</keyword>
</DOC>